{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:04:48Z","timestamp":1758845088950,"version":"3.44.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:p>Cystinosis is a rare autosomal recessive lysosomal storage disease caused by a defective lysosomal cystine carrier protein, cystinosin, resulting in formation and deposition of cystine crystals throughout the body. The renal manifestations of the disease have long been studied, but the musculoskeletal consequences of the disease are generally less well understood. Limb deformities, scoliosis, myopathy and low bone mineral density are associated with cystinosis and can lead to pain, fragility fractures, bone deformity, and difficulty ambulating. Although potentially exacerbated by renal disease and post-transplant medications, it has been found that the musculoskeletal manifestations of cystinosis are also due to inherent dysfunction caused by the mutation of cystinosin. Surgical intervention can provide solutions to the bony symptoms of cystinosis. Early referral to an orthopedic surgeon and evaluation for corrective scoliosis surgery, guided growth for growing children with lower extremity deformity and formal osteotomies for deformity correction in skeletally mature individuals may improve physical function and decrease pain. Standard principles of operative treatment of scoliosis and of bone deformity correction utilized for the treatment of bone deformity in other metabolic bone disease may be applied to patients with cystinosis in the absence of cystinosis-specific studies of the efficacy and outcomes of orthopedic surgery.<\/jats:p>","DOI":"10.3389\/fneph.2025.1624586","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:18:10Z","timestamp":1758773890000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The assessment and treatment of the musculoskeletal manifestations of cystinosis"],"prefix":"10.3389","volume":"5","author":[{"given":"Priya","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u2019Arcy","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Sharkey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019111172","article-title":"Nephropathic cystinosis: A distinct form of CKD\u2013mineral and bone disorder that provides novel insights into the regulation of FGF23 - PMC","volume":"31","author":"Florenzano","year":"2020","journal-title":"JASN"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfx362","article-title":"Bone disease in nephropathic cystinosis is related to cystinosin-induced osteoclastic dysfunction","author":"Claramunt-Taberner","year":"2018","journal-title":"Nephrol Dialysis Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12134","article-title":"Management of bone disease in cystinosis: Statement from an international conference","volume":"42","author":"Hohenfellner","year":"2019","journal-title":"J Inher Metab Disea"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2016.55","article-title":"Skeletal implications and management of cystinosis: three case reports and literature review","volume":"5","author":"Bacchetta","year":"2016","journal-title":"BoneKEy Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-14-00082","article-title":"Contemporary medical and surgical management of X-linked hypophosphatemic rickets","volume":"23","author":"Sharkey","year":"2015","journal-title":"J Am Acad Orthopedic Surgeons"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.21.7622-7632.2002","article-title":"Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis","volume":"22","author":"Cherqui","year":"2002","journal-title":"Mol Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2019.01.015","article-title":"Intrinsic bone defects in cystinotic mice","volume":"189","author":"Battafarano","year":"2019","journal-title":"Am J Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12967-015-0494-0","article-title":"Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient","volume":"13","author":"Conforti","year":"2015","journal-title":"J Transl Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1093-5","article-title":"Osteopenia and fractures in cystinotic children post renal transplantation","volume":"18","author":"Zimakas","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3902-x","article-title":"Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment","volume":"33","author":"Bertholet-Thomas","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00727.x","article-title":"Severe bone disease and low bone mineral density after juvenile renal failure","volume":"63","author":"Groothoff","year":"2003","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015020152","article-title":"Fracture burden and risk factors in childhood CKD: results from the CKiD cohort study","volume":"27","author":"Denburg","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093109","article-title":"Bone disease in nephropathic cystinosis: beyond renal osteodystrophy","volume":"21","author":"Machuca-Gayet","year":"2020","journal-title":"IJMS"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.11.017","article-title":"Grip strength in adults and children with cystinosis","volume":"6","author":"Iyob-Tessema","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020552","article-title":"Cystinosis","volume":"347","author":"Gahl","year":"2002","journal-title":"NEJM"},{"key":"B16","first-page":"25","article-title":"Carnitine profile and effect of suppletion in children with renal fanconi syndrome due to cystinosis","volume-title":"JIMD reports volume 16.","author":"Besouw","year":"2014"},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13023-016-0426-y","article-title":"Cystinosis: a review","volume":"11","author":"Elmonem","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00467-009-1248-0","article-title":"Limitations of dual x-ray absorptiometry in children with chronic kidney disease","volume":"25","author":"Weber","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-012-2116-x","article-title":"Assessment of dual-energy X-ray absorptiometry measures of bone health in pediatric chronic kidney disease","volume":"27","author":"Griffin","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl (2011)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.07.038","article-title":"Chiari I malformation in nephropathic cystinosis","volume":"167","author":"Rao","year":"2015","journal-title":"J Pediatr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1624586\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:18:11Z","timestamp":1758773891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1624586\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":22,"alternative-id":["10.3389\/fneph.2025.1624586"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2025.1624586","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"article-number":"1624586"}}